The classic neuroendocrine markers (synaptophysin, chromogranin A, and NCAM) are usually used for diagnosis (Miyauchi et al., 2015) of the tumor biopsy sample and the cisplatin-etoposide combination is used as standard first line chemotherapy (Byers and Rudin, 2015). Here, SYP is linked to neoplasm.